Oracle's AI Ambitions Meet a $10 Billion Funding Test as Microsoft Lets a Cloud Deal Lapse
Published on 11/16/2026 at 15:10 | Editorial boerse-global.deOracle is discovering that building out artificial intelligence infrastructure is a two-front campaign: one fought in the capital markets, the other in the shifting loyalties of its partners. On Friday, the stock came under pressure as part of a broader retreat from AI-linked equities, with fresh concerns over how the sector will finance its buildout weighing on shares. Oracle closed the session at 113.70 EUR, down 1.1%.
The funding side of the equation is already in motion. In a mandatory disclosure dated 4 November, Oracle confirmed the completion of its equity and debt placements: roughly 86.2 million common shares issued alongside notes totaling $10 billion. Proceeds are earmarked for general corporate purposes, which may include investments and debt repayment. Oracle had fixed the share price at $116.00 per share on 2 November, while the bonds are split across five tranches maturing between 2029 and 2046. Coupons scale with duration—the 2029 tranche carries 7.000%, rising to 8.650% for the paper due in 2046.
A Lapsed Lease and a Cancelled Chip Deal
On the partner front, Bloomberg reported on 6 November that Microsoft is pulling back an agreement to lease AI computing capacity from Oracle. The arrangement dates to 2023. Microsoft did not renew the contract and has already begun switching off capacity, according to Reuters, which cited Bloomberg and people familiar with the matter. The Oracle hardware in question ran on an older generation of Nvidia chips. Notably, the reported wind-down is not a termination confirmed by Oracle. The company told Reuters that demand for its OCI AI infrastructure remains strong—including for earlier-generation graphics processors.
Should investors sell immediately? Or is it worth buying Oracle?
That report follows a Financial Times story on 4 November about Oracle cancelling a separate AI contract: a five-year agreement with Tencent for the rental of AI chips. The FT estimated the deal's value at $7 billion and reported that Oracle withdrew after US authorities raised concerns. Neither Oracle nor Tencent publicly confirmed the reported cancellation.
Health Network Expansion Offers a Counterweight
Not every headline pointed the same direction. Oracle Health announced Friday that its health information exchange network is widening: the US Department of Veterans Affairs and the US Department of War have joined the Oracle Health Information Network as of 5 November. According to the company, the two agencies' participation extends nationwide sharing of health information—a development rooted in the health business, distinct from the media reports concerning AI computing capacity and AI chips.
Analyst Backing and a Date for the Diary
Media reports indicate that analyst Mark Moerdler reaffirmed an "Outperform" rating and a $325 price target on 10 November. Oracle's virtual annual shareholder meeting is scheduled for 18 November at 9 a.m. Central Time, according to the company.
Ad
Oracle Stock: New Analysis - 16 November
Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
